Literature DB >> 17827693

Antitumor and cytotoxic effects of Phyllanthus polyphyllus on Ehrlich ascites carcinoma and human cancer cell lines.

Balasubramanian Rajkapoor1, Marimuthu Sankari, Mohan Sumithra, Jayaraman Anbu, Narayanaswamy Harikrishnan, Manavalan Gobinath, Venkatesan Suba, Ramachandran Balaji.   

Abstract

To evaluate the antitumor and cytotoxic activity of methanol extract of Phyllanthus polyphyllus (MPP) in mice and human cancer cell lines, the antitumor activity of MPP was evaluated against an Ehrlich ascites carcinoma (EAC) tumor model. The activity was assessed using survival time, hematological studies, lipid peroxidation (LPO), antioxidant enzymes such as superoxide dismutase (SOD), catalase, glutathione peroxidase (GPx), glutathione S-transferase (GST), solid tumor mass, and short-term in vitro cytotoxicity. The cytotoxic activity of MPP was evaluated using human breast cancer (MCF7), colon cancer (HT29), and liver cancer (HepG2) cell lines Oral administration of MPP (200 and 300 mg/kg) increased the survival time and significantly reduced the solid tumor volume in a dose-dependent manner. Hematological parameters, protein, and packed cellular volume (PCV), which were altered by tumor inoculation, were restored. MPP significantly decreased the levels of LPO, GPx, GST, and significantly increased the levels of SOD and CAT. In a cytotoxicity study against human cancer cell lines, MPP was found to have IC50 values of 27, 42 and 38 microg/ml on MCF-7, HT-29, and HepG2 cells respectively. MPP possessed significant antitumor and cytotoxic activity on EAC and human cancer cell lines.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17827693     DOI: 10.1271/bbb.70149

Source DB:  PubMed          Journal:  Biosci Biotechnol Biochem        ISSN: 0916-8451            Impact factor:   2.043


  7 in total

1.  Growth inhibitory effects of Phyllanthus niruri extracts in combination with cisplatin on cancer cell lines.

Authors:  Raimundo Fernandes Araújo; Luiz Alberto Lira Soares; Cínthia Raquel da Costa Porto; Ranniere Gurgel Furtado de Aquino; Hugo Gonçalo Guedes; Pedro Ros Petrovick; Tatiane Pereira de Souza; Aurigena Antunes Araújo; Gerlane Coelho Bernardo Guerra
Journal:  World J Gastroenterol       Date:  2012-08-21       Impact factor: 5.742

2.  Antimetastatic effects of Phyllanthus on human lung (A549) and breast (MCF-7) cancer cell lines.

Authors:  Sau Har Lee; Indu Bala Jaganath; Seok Mui Wang; Shamala Devi Sekaran
Journal:  PLoS One       Date:  2011-06-16       Impact factor: 3.240

3.  Growth inhibition of human gynecologic and colon cancer cells by Phyllanthus watsonii through apoptosis induction.

Authors:  Sujatha Ramasamy; Norhanom Abdul Wahab; Nurhayati Zainal Abidin; Sugumaran Manickam; Zubaidah Zakaria
Journal:  PLoS One       Date:  2012-04-20       Impact factor: 3.240

Review 4.  The Genus Phyllanthus: An Ethnopharmacological, Phytochemical, and Pharmacological Review.

Authors:  Xin Mao; Ling-Fang Wu; Hong-Ling Guo; Wen-Jing Chen; Ya-Ping Cui; Qi Qi; Shi Li; Wen-Yi Liang; Guang-Hui Yang; Yan-Yan Shao; Dan Zhu; Gai-Mei She; Yun You; Lan-Zhen Zhang
Journal:  Evid Based Complement Alternat Med       Date:  2016-04-20       Impact factor: 2.629

5.  Cytotoxic and anti-proliferative effects of Rosa beggeriana Schrenk extracts on human liver and breast cancer cells.

Authors:  Ozra Zarei; Mohammad Mehdi Yaghoobi
Journal:  Avicenna J Phytomed       Date:  2019 Jul-Aug

6.  A comparative study of biological potentiality and EAC cell growth inhibition activity of Phyllanthus acidus (L.) fruit pulp and seed in Bangladesh.

Authors:  Ajmeri Sultana Shimu; Masum Miah; Mutasim Billah; Sumon Karmakar; Sumon Chandro Mohanto; Ratna Khatun; Md Abu Reza; Kazi Md Faisal Hoque
Journal:  Saudi J Biol Sci       Date:  2021-01-16       Impact factor: 4.219

7.  Antiproliferative activity and induction of apoptotic by ethanolic extract of Alpinia galanga rhizhome in human breast carcinoma cell line.

Authors:  Saeed Samarghandian; Mousa-Al-Reza Hadjzadeh; Jalil Tavakkol Afshari; Mohadeseh Hosseini
Journal:  BMC Complement Altern Med       Date:  2014-06-17       Impact factor: 3.659

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.